| 标题 |
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Gastroenterology & Hepatology 作者:Vipul Jairath; Silvio Danese; Geert R D'Haens; Brian G Feagan; Laurent Peyrin-Biroulet; et al 出版日期:2025-11-01 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)